Registry for Longitudinal Evaluation of Heart Transplanted Patients
1 other identifier
observational
60
1 country
1
Brief Summary
The overall objective of compiling this registry is to obtain a complete collection of data, in a dedicated database, on all patients who have undergone transplantation at our Center in order to assess the main causes of mortality, hospitalization, and morbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 29, 2023
CompletedFirst Submitted
Initial submission to the registry
December 5, 2025
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedFebruary 25, 2026
December 1, 2025
5.5 years
December 5, 2025
February 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall Mortality in Heart Transplant Recipients
The primary objective of this registry is to evaluate overall mortality of the cohort of heart transplanted patients at Fondazione IRCCS Policlinico San Matteo.
After 1 month, 6 months, one year, and 5 years
Secondary Outcomes (1)
Cause-Specific Mortality, Morbidity, and Hospitalization
After 1 month, 6 months, one year, and 5 years
Eligibility Criteria
The objective of the registry is to have an up-to-date, high quality and exhaustive data collection for the evaluation of the overall survival in the population of heart transplanted recipients and the incidence of hearth, kidney, infectious complications over the last thirty years and their determinants.
You may qualify if:
- To be included in the study the patient must:
- Give written informed consent to participate for the prospective evaluations
- Be a heart transplanted patient
- Be aged 18 years and over
You may not qualify if:
- Withdrawn of the consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione IRCCS Policlinico San Matteo
Pavia, 27100, Italy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
December 5, 2025
First Posted
February 25, 2026
Study Start
June 28, 2018
Primary Completion
December 29, 2023
Study Completion
December 29, 2023
Last Updated
February 25, 2026
Record last verified: 2025-12